OptiNose (OPTN) Tops Q2 EPS by 13c

OptiNose (NASDAQ: OPTN) reported Q2 EPS of $0.02, $0.13 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $19.45 million versus the consensus estimate of $16.71 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth